News & Events about Paragon 28 Inc.
Paragon 28, Inc. (NYSE: FNA) (Paragon), a leading medical device company exclusively focused on the foot and ankle orthopedic market, announced today the pricing of the previously announced underwritten public offering of 6,500,000 shares of its common stock at a public offering price of $17.00 per...
Paragon 28, Inc. (NYSE:FNA Get Rating) insider Matthew Jarboe sold 35,110 shares of the stock in a transaction dated Friday, December 23rd. The shares were sold at an average price of $20.93, for a total transaction of $734,852.30. Following the completion of the sale, the insider now owns 271,764 ...
Paragon 28, Inc. (NYSE:FNA Get Rating) major shareholder Mvm Partners Llp sold 27,487 shares of Paragon 28 stock in a transaction on Monday, October 31st. The stock was sold at an average price of $19.91, for a total transaction of $547,266.17. Following the completion of the transaction, the ...
Paragon 28, Inc. (NYSE:FNA Get Rating) major shareholder Lee Rosenthal sold 56,296 shares of Paragon 28 stock in a transaction dated Tuesday, July 26th. The stock was sold at an average price of $18.87, for a total value of $1,062,305.52. Following the transaction, the insider now owns 993,407 ...
Paragon 28, Inc. (NYSE:FNA Get Rating) major shareholder Lee Rosenthal sold 73,408 shares of the businesss stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $19.32, for a total transaction of $1,418,242.56. Following the transaction, the insider now owns ...